IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 115

Article Submitted : 19456

Article Published : 8041

Total Authors : 21252

Total Reviewer : 769

Total Countries : 144

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Prospective observational study on the prescription pattern of medications in chronic kidney disease patients at tertiary care hospital
Authors Name: Dr. Luai Fahd Mohammed Alhetari , Dr. Anshu Singh , Dr. Mohammed Saleh , Dr. Balakeshwa Ramaiah
Download E-Certificate: Download
Author Reg. ID:
IJRTI_185334
Published Paper Id: IJRTI2302071
Published In: Volume 8 Issue 2, February-2023
DOI: http://doi.one/10.1729/Journal.43671
Abstract: Background: The kidney is the structural and functional unit responsible for regulating homeostasis, equilibrium(acid-base) and electrolytes, also kidney plays a major role in the disposition of many drugs. CKD patients were commonly present with several other comorbidities of which HTN and DM are the most common. a large number of medications usually prescribed to CKD patients that are complicated and require dosing and frequent monitoring. The objective of the study is to analyze the prescription pattern of medications in CKD patients Method: a prospective observational study on the prescription pattern of medications in chronic kidney disease patients which is based on the collection of data on a daily visit to the department of nephrology, medicines and HICU in tertiary care hospital. The patient who met the criteria were involved in the study. WHO Prescribing Indicator, ATC classification of drugs and therapeutic class drug distribution were used for the analysis of drugs. Result: Out of 60 collected cases, 70% were male and 30% were female. The study population were also having comorbidities along with CKD in which HTN was the highest among CKD patients with 75% followed by DM (68%), Anemia (30%), Respiratory Disorder (27%), CVD (18%), Thyroid Disorder (15%) and UTI (13%). WHO drug prescribing indicator showed that the average number of drugs prescribed per patient was 12, the percentage of drugs prescribed by generic name was (390) 54%, the percentage of a patient with an injection prescribed was (246) 34%, the percentage of drugs prescribed from essential medicine list was (580) 80%. Antihypertensive drugs (163) 22.5% were commonly used drugs followed by vitamins (141)19.44%, minerals (99) 13.65%, antimicrobial (93) 13.2%, hemopoietic agents (53) 7.3%, anti-diabetic agent (52) 7.2% and hypolipidemic agent (39) 5.4%. Conclusion: An overall understanding of medications used in CKD management, their complications and comorbidities associated with it, helps physicians and prescriber in better control and management of CKD patients, adverse effects and toxicities of the drugs, which in turn leads to improving patient compliance to treatment therapy. After the analysis of all the CKD cases, it was found that symptoms along with the comorbidities were managed accordingly. Meanwhile, the rationality of prescribing was followed.
Keywords: Chronic kidney disease, comorbidities, prescription pattern, dialysis.
Cite Article: "Prospective observational study on the prescription pattern of medications in chronic kidney disease patients at tertiary care hospital", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 2, page no.429 - 438, February-2023, Available :http://www.ijrti.org/papers/IJRTI2302071.pdf
Downloads: 000205221
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2302071
Registration ID:185334
Published In: Volume 8 Issue 2, February-2023
DOI (Digital Object Identifier): http://doi.one/10.1729/Journal.43671
Page No: 429 - 438
Country: bengaluru, karnataka, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2302071
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2302071
Share Article:

Share Facebook Twitter Google+ Pinterest LinkedIn Email Tumblr WhatsApp Google Gmail

Click Here to Download This Article

Article Preview
Click Here to Download This Article
Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300
IJRTI

WhatsApp
Click Here

Indexing Partner
Copyright © 2025 - All Rights Reserved - IJRTI